Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
Journal article published in 2020 by
Darren R. Feldman 
,
Yasser Ged ,
Chung‐Han Lee,
Andrea Knezevic ,
Ana M. Molina,
Ying‐Bei Chen,
Joshua Chaim,
Devyn T. Coskey,
Samuel Murray ,
Satish K. Tickoo,
Victor E. Reuter,
Sujata Patil,
Han Xiao,
Jahan Aghalar,
Arlyn J. Apollo
and other authors.
,
Yasser Ged ,
Chung‐Han Lee,
Andrea Knezevic ,
Ana M. Molina,
Ying‐Bei Chen,
Joshua Chaim,
Devyn T. Coskey,
Samuel Murray ,
Satish K. Tickoo,
Victor E. Reuter,
Sujata Patil,
Han Xiao,
Jahan Aghalar,
Arlyn J. Apollo
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 